1067652-29-2

Upstream product

• 1067652-68-9 C₁₀H₁₇NO₆S 
• 4187-56-8 (S)-1-(p-chlorophenyl)ethylamine 

Downstream Products

• 1067651-50-6 (1R,2R,4S)-4-(methanesulfonyl-methyl-amino)-cyclopentane-1,2-dicarboxylic acid 1-{[(1S,2S,4R)-4-((S)-1-benzylcarbamoyl-2-methyl-propylcarbamoyl)-1-(3,5-difluoro-phenoxymethyl)-2-hydroxy-4-methoxy-butyl]-amide} 2-{[(S)-1-(4-chloro-phenyl)-ethyl]-amide} 
• 1067652-72-5 (1R,2R,4S)-4-(methanesulfonyl-methyl-amino)-2-[(S)-1-p-tolyl-ethylcarbamoyl]-cyclopentanecarboxylic acid 

Relevant academic research and scientific papers

AMIDE DERIVATIVES AS INHIBITORS OF ASPARTYL PROTEASES

The invention provides compounds of the formula (I). N-oxides, addition salts, quaternary amines, metal complexes, stereochemically isomeric forms and metabolites thereof, wherein W is H,C 1-C 6 alkyl, C 3-C 6 cycloalkyl, aryl or heterocyclyl; Q is aryl or heterocyclyl; A is a five or six membered saturated, partially unsaturated or aromatic ring; D is (II) or (III) the other variables are as defined in the specification. The compounds of the invention are inhibitors of BACE and are among other things useful for the treatment and/or prevention of conditions associated with BACE activity such as Alzheimer's disease.